Caceres D, Rodriguez-Barradas M, Whitaker M, Jackson B, Kim L, Surie D
J Fungi (Basel). 2023; 9(4).
PMID: 37108910
PMC: 10145596.
DOI: 10.3390/jof9040456.
Zaragoza R, Sole-Violan J, Cusack R, Rodriguez A, Reyes L, Martin-Loeches I
Diagnostics (Basel). 2023; 13(3).
PMID: 36766545
PMC: 9914306.
DOI: 10.3390/diagnostics13030440.
Hoque M, Rahman M, Sarkar M, Habib M, Akter S, Banu T
PLoS One. 2023; 18(1):e0278134.
PMID: 36656835
PMC: 9851516.
DOI: 10.1371/journal.pone.0278134.
Hoenigl M, Lewis R, van de Veerdonk F, Verweij P, Cornely O
J Antimicrob Chemother. 2022; 77(Suppl_2):ii21-ii34.
PMID: 36426674
PMC: 9693803.
DOI: 10.1093/jac/dkac353.
Waldeck F, Boroli F, Zingg S, Walti L, Wendel-Garcia P, Conen A
Influenza Other Respir Viruses. 2022; 17(1):e13059.
PMID: 36394086
PMC: 9835444.
DOI: 10.1111/irv.13059.
An overview of COVID-19 related to fungal infections: what do we know after the first year of pandemic?.
Vitale R, Afeltra J, Seyedmousavi S, Giudicessi S, Romero S
Braz J Microbiol. 2022; 53(2):759-775.
PMID: 35315001
PMC: 8936386.
DOI: 10.1007/s42770-022-00704-6.
Novel Clinical and Laboratorial Challenges in Aspergillosis.
Sabino R, Verissimo C
Microorganisms. 2022; 10(2).
PMID: 35208714
PMC: 8877562.
DOI: 10.3390/microorganisms10020259.
Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta-analysis.
Shi C, Shan Q, Xia J, Wang L, Wang L, Qiu L
Mycoses. 2021; 65(2):152-163.
PMID: 34882852
PMC: 9306612.
DOI: 10.1111/myc.13410.
COVID-19-associated mucormycosis: Case report and systematic review.
Dilek A, Ozaras R, Ozkaya S, Sunbul M, Sen E, Leblebicioglu H
Travel Med Infect Dis. 2021; 44:102148.
PMID: 34454090
PMC: 8387131.
DOI: 10.1016/j.tmaid.2021.102148.
COVID-19-Associated Pulmonary Aspergillosis at an Academic Medical Center in the Midwestern United States.
Wasylyshyn A, Wasylyshyn G, Linder K, Miceli M
Mycopathologia. 2021; 186(4):499-505.
PMID: 34143393
PMC: 8211947.
DOI: 10.1007/s11046-021-00564-y.
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.
Vanderbeke L, Janssen N, Bergmans D, Bourgeois M, Buil J, Debaveye Y
Intensive Care Med. 2021; 47(6):674-686.
PMID: 34050768
PMC: 8164057.
DOI: 10.1007/s00134-021-06431-0.
Recent Trends in the Epidemiology of Fungal Infections.
Seagle E, Williams S, Chiller T
Infect Dis Clin North Am. 2021; 35(2):237-260.
PMID: 34016277
PMC: 10989278.
DOI: 10.1016/j.idc.2021.03.001.
Epidemiological Correlation of Pulmonary Infections with Ambient Pollutions and Influenza A (H1N1) in Southern Taiwan.
Liu J, Ku Y, Chao C, Ou H, Ho C, Chan K
J Fungi (Basel). 2021; 7(3).
PMID: 33808688
PMC: 8003483.
DOI: 10.3390/jof7030227.
Aspergillosis Complicating Severe Coronavirus Disease.
Marr K, Platt A, Tornheim J, Zhang S, Datta K, Cardozo C
Emerg Infect Dis. 2020; 27(1).
PMID: 33084566
PMC: 7774554.
DOI: 10.3201/eid2701.202896.
Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients.
Ichai P, Saliba F, Baune P, Daoud A, Coilly A, Samuel D
Crit Care. 2020; 24(1):538.
PMID: 32867810
PMC: 7458783.
DOI: 10.1186/s13054-020-03221-w.
Ventilator-associated pneumonia involving in a patient with coronavirus disease 2019 (COVID-19) from Argentina.
Fernandez N, Caceres D, Beer K, Irrazabal C, Delgado G, Farias L
Med Mycol Case Rep. 2020; 31:19-23.
PMID: 32837881
PMC: 7335419.
DOI: 10.1016/j.mmcr.2020.07.001.
Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China.
Song G, Liang G, Liu W
Mycopathologia. 2020; 185(4):599-606.
PMID: 32737747
PMC: 7394275.
DOI: 10.1007/s11046-020-00462-9.
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
Verweij P, Rijnders B, Bruggemann R, Azoulay E, Bassetti M, Blot S
Intensive Care Med. 2020; 46(8):1524-1535.
PMID: 32572532
PMC: 7306567.
DOI: 10.1007/s00134-020-06091-6.
Detecting influenza-associated pulmonary aspergillosis by determination of galactomannan in broncho-alveolar lavage fluid and in serum: should we add (1,3)-beta-D-glucan to improve efficacy.
Honore P, Barreto Gutierrez L, Kugener L, Redant S, Attou R, Gallerani A
Crit Care. 2020; 24(1):294.
PMID: 32503673
PMC: 7275585.
DOI: 10.1186/s13054-020-03030-1.
Correction to: International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe.
Thevissen K, Jacobs C, Holtappels M, Toda M, Verweij P, Wauters J
Crit Care. 2020; 24(1):186.
PMID: 32349786
PMC: 7191756.
DOI: 10.1186/s13054-020-02901-x.
